| 1 | [SID103566330] | Active | Kd | 0.005 | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in phosphate buffer by isothermal titration calorimetric assay [AID642884, Type: Literature] | Riboflavin-binding protein [gi:132070] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Active | | Kd | 0.005 [uM] | | BioAssay | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in phosphate buffer by isothermal titration calorimetric assay | | AID | 642884 | | BioAssay type | Literature | | Target | Riboflavin-binding protein [gi:132070] | | PubMed | 21686082 | | Data Table |  |
|
| 2 | [SID103566330] | Active | Kd | 0.0066 | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in 0.1 M phosphate buffer by isothermal titration calorimetric assay [AID642882, Type: Literature] | Riboflavin-binding protein [gi:132070] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Active | | Kd | 0.0066 [uM] | | BioAssay | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in 0.1 M phosphate buffer by isothermal titration calorimetric assay | | AID | 642882 | | BioAssay type | Literature | | Target | Riboflavin-binding protein [gi:132070] | | PubMed | 21686082 | | Data Table |  |
|
| 3 | [SID103566330] | Active | Kd | 0.034 | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 9 in 0.1 M Tris by isothermal titration calorimetric assay [AID642880, Type: Literature] | Riboflavin-binding protein [gi:132070] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Active | | Kd | 0.034 [uM] | | BioAssay | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 9 in 0.1 M Tris by isothermal titration calorimetric assay | | AID | 642880 | | BioAssay type | Literature | | Target | Riboflavin-binding protein [gi:132070] | | PubMed | 21686082 | | Data Table |  |
|
| 4 | [SID103566330] | Active | Kd | 0.046 | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 4 in 0.1 M NaAc by isothermal titration calorimetric assay [AID642881, Type: Literature] | Riboflavin-binding protein [gi:132070] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Active | | Kd | 0.046 [uM] | | BioAssay | Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 4 in 0.1 M NaAc by isothermal titration calorimetric assay | | AID | 642881 | | BioAssay type | Literature | | Target | Riboflavin-binding protein [gi:132070] | | PubMed | 21686082 | | Data Table |  |
|
| 5 | [SID103566330] | Active | Ki | 0.35 | Competitive inhibition of chicken riboflavin binding protein by surface plasmon resonance assay [AID642883, Type: Literature] | Riboflavin-binding protein [gi:132070] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Active | | Ki | 0.35 [uM] | | BioAssay | Competitive inhibition of chicken riboflavin binding protein by surface plasmon resonance assay | | AID | 642883 | | BioAssay type | Literature | | Target | Riboflavin-binding protein [gi:132070] | | PubMed | 21686082 | | Data Table |  |
|
| 6 | [SID17389635] | Active | Potency | 5.9557 | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 5.9557 [uM] | | BioAssay | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay | | AID | 651754 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17389635] | Active | Potency | 7.4978 | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 7.4978 [uM] | | BioAssay | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay | | AID | 651755 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID17389635] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 9 | [SID17389635] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 10 | [SID17389635] | Active | Potency | 31.6228 | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region [AID923, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region | | AID | 923 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID17389635] | Active | Potency | 39.8107 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells [AID946, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells | | AID | 946 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID17389635] | Active | Potency | 39.8107 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells [AID961, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells | | AID | 961 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID48416517] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 48416517 | | CID | 493570 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID46393994] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Complexes Of Dodecin With Flavin And Flavin-Like Ligands [gi:90109102] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 46393994 | | CID | 493570 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Complexes Of Dodecin With Flavin And Flavin-Like Ligands [gi:90109102] | | PubMed | 18093984 | | Data Table |  |
|
| 15 | [SID47193671] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective Ga16 antagonists [AID651952, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective Ga16 antagonists | | AID | 651952 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 16 | [SID47193671] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists [AID651787, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists | | AID | 651787 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 17 | [SID47193671] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 18 | [SID47193671] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 19 | [SID17389635] | Active | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 20 | [SID47193671] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 21 | [SID47193671] | Active | | | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID652036, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 652036 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 22 | [SID47193671] | Active | | | Fluorescence-based biochemical high throughput counterscreen assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe [AID652035, Type: screening] | ALB gene product [Bos taurus] [gi:30794280] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput counterscreen assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe | | AID | 652035 | | BioAssay type | screening | | Target | ALB gene product [Bos taurus] [gi:30794280] | | PubMed | | | Data Table |  |
|
| 23 | [SID47193671] | Active | | | Fluorescence-based biochemical high throughput counterscreen assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe [AID652035, Type: screening] | ALB gene product [Bos taurus] [gi:30794280] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput counterscreen assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe | | AID | 652035 | | BioAssay type | screening | | Target | ALB gene product [Bos taurus] [gi:30794280] | | PubMed | | | Data Table |  |
|
| 24 | [SID47193671] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 25 | [SID47193671] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 26 | [SID47193671] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID651783, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651783 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 27 | [SID47193671] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID651783, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651783 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 28 | [SID47193671] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify hTAAR1 agonists that also desensitize TAAR1 receptor response. [AID651951, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify hTAAR1 agonists that also desensitize TAAR1 receptor response. | | AID | 651951 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 29 | [SID47193671] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify hTAAR1 agonists that also desensitize TAAR1 receptor response. [AID651951, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 47193671 | | CID | 493570 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify hTAAR1 agonists that also desensitize TAAR1 receptor response. | | AID | 651951 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 30 | [SID103566330] | Unspecified | | | TP_TRANSPORTER: inhibition of PAH uptake (PAH: 20 uM, Riboflavin: 1000 uM) in OAT-expressing COS-7 cells [AID681019, Type: other] | Solute carrier family 22 member 6 [gi:81901833] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of PAH uptake (PAH: 20 uM, Riboflavin: 1000 uM) in OAT-expressing COS-7 cells | | AID | 681019 | | BioAssay type | other | | Target | Solute carrier family 22 member 6 [gi:81901833] | | PubMed | | | Data Table |  |
|
| 31 | [SID17389635] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID103566330] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 33 | [SID103566330] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 34 | [SID103566330] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 35 | [SID103566330] | Unspecified | | | Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset [AID588220, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset | | AID | 588220 | | BioAssay type | Literature | | Target | | | PubMed | 20020916 | | Data Table |  |
|
| 36 | [SID103566330] | Unspecified | | | Compound was tested for the inhibition of malate dehydrogenase (MDH) at 100 uM [AID106804, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Compound was tested for the inhibition of malate dehydrogenase (MDH) at 100 uM | | AID | 106804 | | BioAssay type | Literature | | Target | | | PubMed | 14521410 | | Data Table |  |
|
| 37 | [SID103566330] | Unspecified | | | Activity at androgen receptor ligand binding domain assessed as inhibition of SRC2-3 interaction at 50 uM after 2 hrs by fluorescence polarization assay [AID329525, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Activity at androgen receptor ligand binding domain assessed as inhibition of SRC2-3 interaction at 50 uM after 2 hrs by fluorescence polarization assay | | AID | 329525 | | BioAssay type | Literature | | Target | | | PubMed | 17911242 | | Data Table |  |
|
| 38 | [SID103566330] | Unspecified | | | Inhibition of chymotrypsin at 250 uM [AID52790, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Inhibition of chymotrypsin at 250 uM | | AID | 52790 | | BioAssay type | Literature | | Target | | | PubMed | 14521410 | | Data Table |  |
|
| 39 | [SID103566330] | Unspecified | | | Inhibition of beta-lactamase at 100 uM [AID43581, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103566330 | | CID | 493570 | | Outcome | Unspecified | | BioAssay | Inhibition of beta-lactamase at 100 uM | | AID | 43581 | | BioAssay type | Literature | | Target | | | PubMed | 14521410 | | Data Table |  |
|
| 40 | [SID17389635] | Inactive | Potency | 8.9125 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Inactive | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 41 | [SID17389635] | Inactive | Potency | 19.9526 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389635] | Inactive | Potency | 19.9526 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389635] | Inactive | Potency | 19.9526 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389635 | | CID | 493570 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 44 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 45 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 46 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 47 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 48 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 49 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 50 | [SID144204364] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 144204364 | | CID | 493570 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|